Wall Street closes lower as surging COVID-19 cases offset vaccine hopes
By Stephen Culp NEW YORK (Reuters) - U.S. stocks closed lower on Friday as investors wrestled with fiscal stimulus developments, concerns over a lengthy rollout of vaccines, and a growing number of state-level shutdowns to combat the spiraling COVID-19 pandemic.
COVID-19 cases offset vaccine hopes" src="https://images.firstpost.com/wp-content/uploads/reuters/11-2020/21/2020-11-20T135230Z_1_LYNXMPEGAJ0VN_RTROPTP_2_USA-STOCKS.jpg" alt="Wall Street closes lower as surging COVID19 cases offset vaccine hopes" width="300" height="225" />
By Stephen Culp
NEW YORK (Reuters) - U.S. stocks closed lower on Friday as investors wrestled with fiscal stimulus developments, concerns over a lengthy rollout of vaccines, and a growing number of state-level shutdowns to combat the spiraling COVID-19 pandemic.
Stay-at-home plays such as Zoom Communications Inc
Throughout the week, the ebb and flow of vaccine news and spiking infections had investors oscillating between economically-sensitive cyclical stocks and pandemic-resistant market leaders.
The S&P 500 and the Dow posted marginal losses for the week, while the tech-laden Nasdaq settled a bit higher from last Friday's close.
"Markets are still stuck in a push-and-pull between the dramatic rise of new COVID cases versus apparent progress on vaccines," said David Carter, chief investment officer at Lenox Wealth Advisors in New York. "This is likely to continue until we have an approved and distributed vaccine."
U.S. Treasury Secretary Steven Mnuchin announced late Thursday that he would allow key pandemic-relief lending programs at the Federal Reserve to expire at the end of the year, saying the $455 billion allocated last spring under the CARES act should be returned to Congress to be reallocated as grants for small companies.
The decision to pull the plug on lending programs deemed essential by the central bank comes at a time of spiraling new coronavirus infections and a fresh wave of layoffs, and was called "disappointing" by Chicago Federal Reserve president Charles Evans.
"This dust-up between the Fed and Treasury could have serious implications, as markets want to see the two institutions working well together," Carter added. "The timing of this dust-up is unfortunate, as the risk of COVID is still very much with us."
Record infection numbers have caused COVID hospitalizations to soar by 50% and have prompted a new round of school and businesses closures, curfews and social distancing restrictions, hobbling the economic recovery from the deepest recession since the Great Depression.
In the latest development in the race to develop a vaccine, Pfizer Inc
Unofficially, the Dow Jones Industrial Average <.DJI> fell 219.95 points, or 0.75%, to 29,263.28, the S&P 500 <.SPX> lost 24.22 points, or 0.68%, to 3,557.65 and the Nasdaq Composite <.IXIC> dropped 49.74 points, or 0.42%, to 11,854.97.
Stay-at-home beneficiary Zoom Video Communications Inc
Gilead Sciences Inc
(Reporting by Stephen Culp; editing by Tom Brown)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Johannes Hellstrom, Bart H.
By Medha Singh and Shivani Kumaresan (Reuters) - Wall Street gained on Friday as Disney and Cisco's upbeat results brought the focus back to corporate earnings at the end of a volatile trading week that saw record surges in coronavirus cases and increased hopes of a working vaccine.
By Sumita Layek (Reuters) - Gold gained as much as 1.1% on Friday as rising global coronavirus infections re-ignited concerns about the economic toll from the pandemic, while scepticism over the reach of a potential COVID-19 vaccine further boosted the safe-haven metal. Spot gold rose 0.8% to $1,890.81 per ounce by 11:33 a.m